• AI Pickup
  • menu
  • U.S. Stock Market Prediction
    • U.S. Stock Forecast Tomorrow
    World Stock Markets
  • ETF Market Prediction
    • ETF Forecast Tomorrow
  • Cryptocurrency Prediction
  • Forex Market Prediction
  • Sign In Sign Up
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
By Wall Street
Price forecast
Financial Info
  • AI Pickup logo
  • U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets
  • Featured and All ETFs ETF Forecast Tomorrow
  • Featured and All Cryptocurrencies
  • Featured and All Forex
  • Sign In Sign Up
By Wall Street
Price forecast
Financial Info
Quick Access Forecast in this page:
Wall street
Forecast
    You are here:
  • Home
  • USA stock market prediction
  • HALO stock forecast

HALO : Halozyme Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 2 Wall Street analysts offering Halozyme Therapeutics stock forecast in the last 6 months have average price target of $55.0 with a high forecast of $60.0 and a low forecast of $50.0. The average Halozyme Therapeutics stock forecast represents a 28.59% increase from the last price of $42.77. From AI system, total return is 2022.2% from 1610 forecasts. For Halozyme Therapeutics stock forecast 2021, 8 predictions are offered for each month of 2021 with average Halozyme Therapeutics stock forecast of $39.84, a high forecast of $42.02, and a low forecast of $37.86. The average Halozyme Therapeutics stock forecast 2021 represents a -6.86% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Halozyme Therapeutics stock forecast of $35.81, a high forecast of $37.3, and a low forecast of $35.22. The average Halozyme Therapeutics stock forecast 2022 represents a -16.27% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Halozyme Therapeutics stock forecast of $41.11, a high forecast of $41.59, and a low forecast of $40.68. The average Halozyme Therapeutics stock forecast 2025 represents a -3.88% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Halozyme Therapeutics stock forecast of $41.96, a high forecast of $42.18, and a low forecast of $41.62. The average Halozyme Therapeutics stock forecast 2026 represents a -1.89% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Halozyme Therapeutics stock forecast of $38.11, a high forecast of $39.81, and a low forecast of $36.6. The average Halozyme Therapeutics stock forecast 2030 represents a -10.89% decrease from the last price of $42.77. For Halozyme Therapeutics stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Halozyme Therapeutics stock forecast of $35.73, a high forecast of $36.3, and a low forecast of $35.08. The average Halozyme Therapeutics stock forecast 2031 represents a -16.45% decrease from the last price of $42.77. Please, see more forecasts below.

subject
Average
Low
High
Change from close on 2021-04-09
HALO : Halozyme Therapeutics stock forecast
$55.0
$50.0
$60.0
28.59%
HALO : Halozyme Therapeutics stock forecast 2021
$39.84
$37.86
$42.02
-6.86%
HALO : Halozyme Therapeutics stock forecast 2022
$35.81
$35.22
$37.3
-16.27%
HALO : Halozyme Therapeutics stock forecast 2023
$39.99
$36.11
$42.74
-6.5%
HALO : Halozyme Therapeutics stock forecast 2024
$41.45
$40.68
$42.55
-3.08%
HALO : Halozyme Therapeutics stock forecast 2025
$41.11
$40.68
$41.59
-3.88%
HALO : Halozyme Therapeutics stock forecast 2026
$41.96
$41.62
$42.18
-1.89%
HALO : Halozyme Therapeutics stock forecast 2027
$41.87
$41.52
$42.16
-2.11%
HALO : Halozyme Therapeutics stock forecast 2028
$41.82
$41.47
$42.21
-2.23%
HALO : Halozyme Therapeutics stock forecast 2029
$41.61
$40.28
$42.2
-2.71%
HALO : Halozyme Therapeutics stock forecast 2030
$38.11
$36.6
$39.81
-10.89%
HALO : Halozyme Therapeutics stock forecast 2031
$35.73
$35.08
$36.3
-16.45%

Table of contents

  • Price target by Wall Street
  • Halozyme Therapeutics stock forecast for upcoming days
  • Long term Halozyme Therapeutics stock forecast
  • Financial Info
  • Frequently Asked Questions (FAQ)
  • 14 Days Historical Data

Statistics

Statistics from all past Buy/Sell opinions in AI Pickup
Total return : 2022.2 %
Number of direction forecasts : 1610

Click to see the forecast history of all tickers

HALO : Halozyme Therapeutics stock forecast Wall Street by analysts

The average Halozyme Therapeutics stock forecast from last 6 month is $55.0, and this show a 53.85% increase in average from the prior price target of the each prediction. Also, this average forecast of $55.0 represents a 73.23% increase from the past average forecast of $31.75, 6 months ago from 8 wall street analysts.

Date
Firm
current price target
previous price target
current rating
2020-12-17
Berenberg
$50.0000
Buy
2020-11-16
Wells Fargo
$60.0000
$39.0000
Overweight
2020-07-02
Piper Sandler
$31.0000
$28.0000
Overweight
2020-07-01
Benchmark
$39.0000
Buy
2020-06-15
Citigroup
$26.0000
$18.0000
Neutral
2020-05-19
Canaccord Genuity
$27.0000
$23.0000
Buy
2020-05-12
JMP Securities
$34.0000
$24.0000
Market Outperform
2020-05-12
JP Morgan
$23.0000
$22.0000
Overweight
2020-05-12
BMO Capital
$35.0000
$27.0000
Outperform
2020-05-04
Cantor Fitzgerald
$39.0000
$35.0000
Overweight

Halozyme Therapeutics stock forecast for upcoming days

HALO forecast chart for short term
Date
Price
Halozyme Therapeutics stock forecast for 2021-04-12
$43.67
Halozyme Therapeutics stock forecast for 2021-04-13
$44.00
Halozyme Therapeutics stock forecast for 2021-04-14
$44.49
Halozyme Therapeutics stock forecast for 2021-04-15
$45.03
Halozyme Therapeutics stock forecast for 2021-04-16
$45.40
Halozyme Therapeutics stock forecast for 2021-04-19
$45.82
Halozyme Therapeutics stock forecast for 2021-04-20
$46.02
Halozyme Therapeutics stock forecast for 2021-04-21
$46.82
Halozyme Therapeutics stock forecast for 2021-04-22
$47.81
Halozyme Therapeutics stock forecast for 2021-04-23
$49.17

Long term Halozyme Therapeutics(HALO) stock forecast for 2021, 2022 (1 year) - 2025, 2026 (5 year) - 2030, and 2031 (10 year)

Forecast for May. 2021 is $42.02 , for Apr. 2022 is $35.86 , for Apr. 2025 is $40.83 , for Apr. 2026 is $41.80 , for Apr. 2030 is $38.77 , and for Apr. 2031 is $35.08.

HALO long term forecast chart
Date
Price
May. 2021
$42.0173049733591
Jun. 2021
$41.4001062060193
Jul. 2021
$40.75206041062
Aug. 2021
$40.0806245807747
Sep. 2021
$39.4064104527549
Oct. 2021
$38.8394551594664
Nov. 2021
$38.3392891903246
Dec. 2021
$37.8584611404473
Jan. 2022
$37.3002504287739
Feb. 2022
$36.7825161131826
Mar. 2022
$36.2749206924167
Apr. 2022
$35.8611539438308
May. 2022
$35.6880146706009
Jun. 2022
$35.5842984242482
Jul. 2022
$35.4753595281671
Aug. 2022
$35.3682280751364
Sep. 2022
$35.2429636648748
Oct. 2022
$35.2169709124363
Nov. 2022
$35.3190174256853
Dec. 2022
$35.598303525827
Jan. 2023
$36.107709832392
Feb. 2023
$36.7434168165675
Mar. 2023
$37.4502096752265
Apr. 2023
$38.1703810552069
May. 2023
$38.8859873504544
Jun. 2023
$39.7853537985705
Jul. 2023
$40.9560535974067
Aug. 2023
$41.7165223505385
Sep. 2023
$42.1940419189464
Oct. 2023
$42.5047499861751
Nov. 2023
$42.7368669868254
Dec. 2023
$42.6473279794849
Jan. 2024
$42.5539262081396
Feb. 2024
$42.5099175519248
Mar. 2024
$42.4556598329273
Apr. 2024
$42.1731788620222
May. 2024
$41.5751080062782
Jun. 2024
$41.2506909138562
Jul. 2024
$41.0646895316051
Aug. 2024
$40.9151916134739
Date
Price
Sep. 2024
$40.8231049721195
Oct. 2024
$40.7498639369703
Nov. 2024
$40.6964669051396
Dec. 2024
$40.683350032717
Jan. 2025
$40.6847305749326
Feb. 2025
$40.7064474335263
Mar. 2025
$40.7557751364321
Apr. 2025
$40.8342112793204
May. 2025
$40.9326979904474
Jun. 2025
$41.0403596267729
Jul. 2025
$41.1503623321922
Aug. 2025
$41.2593149992679
Sep. 2025
$41.3641673526808
Oct. 2025
$41.4606297275914
Nov. 2025
$41.5400470538499
Dec. 2025
$41.590531520308
Jan. 2026
$41.6233856708405
Feb. 2026
$41.665607540497
Mar. 2026
$41.7250397107415
Apr. 2026
$41.8015857846114
May. 2026
$41.8899714711484
Jun. 2026
$41.9796791731736
Jul. 2026
$42.0585250031534
Aug. 2026
$42.1185080131847
Sep. 2026
$42.1575212410831
Oct. 2026
$42.1780469086379
Nov. 2026
$42.1837825279177
Dec. 2026
$42.1771208092464
Jan. 2027
$42.1596557452569
Feb. 2027
$42.1312083130185
Mar. 2027
$42.0924154210348
Apr. 2027
$42.0435352754557
May. 2027
$41.9855421741541
Jun. 2027
$41.9201368349718
Jul. 2027
$41.8497877087031
Aug. 2027
$41.7766396277678
Sep. 2027
$41.7037876232179
Oct. 2027
$41.6351288865449
Nov. 2027
$41.5738135327793
Dec. 2027
$41.5230433181819
Date
Price
Jan. 2028
$41.4865088693239
Feb. 2028
$41.4710302713155
Mar. 2028
$41.4838407391067
Apr. 2028
$41.5312749302455
May. 2028
$41.6151368450336
Jun. 2028
$41.7283447494622
Jul. 2028
$41.8564494273744
Aug. 2028
$41.9809667611752
Sep. 2028
$42.0857571451121
Oct. 2028
$42.1611326844352
Nov. 2028
$42.2030756914495
Dec. 2028
$42.2137585405643
Jan. 2029
$42.198693072396
Feb. 2029
$42.1637663871657
Mar. 2029
$42.1127138671775
Apr. 2029
$42.0476803448512
May. 2029
$41.9695678203376
Jun. 2029
$41.8773296980419
Jul. 2029
$41.7662838397764
Aug. 2029
$41.6252068848856
Sep. 2029
$41.4286362642257
Oct. 2029
$41.1383264828511
Nov. 2029
$40.7395184772249
Dec. 2029
$40.2763895982464
Jan. 2030
$39.8113534365063
Feb. 2030
$39.4086998806186
Mar. 2030
$39.0691174803169
Apr. 2030
$38.7672159641793
May. 2030
$38.4797189084659
Jun. 2030
$38.2041234348956
Jul. 2030
$37.9316298778746
Aug. 2030
$37.6627615352003
Sep. 2030
$37.399274208693
Oct. 2030
$37.1370434854494
Nov. 2030
$36.8710877081476
Dec. 2030
$36.5950894329832
Jan. 2031
$36.3005691699885
Feb. 2031
$35.9744238177354
Mar. 2031
$35.5790069195465
Apr. 2031
$35.080255920107

Financial Data for Halozyme Therapeutics stock

Market Cap
6129026560
Held Percent By Insiders
1.2159999%
Held Percent By Institutions
98.414004%
Sector
Healthcare
Website
http://www.halozyme.com
currency
USD

Forward PE
16.078947
Trailing PE
47.0
Enterprise Value
5.817210368E9
Enterprise To Ebitda
39.888
Enterprise To Revenue
21.739

Average 10 day Volume
790200
Average Volume
1451598
Fifty Two Week High
$56.4
Fifty Two Week Low
$17.74

Frequently Asked Questions about Halozyme Therapeutics stock forecast

Is Halozyme Therapeutics a good long term stock?

From Halozyme Therapeutics stock forecast 2021, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for May. 2021 is $42.0173049733591

From Halozyme Therapeutics stock forecast 2022, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2022 is $35.8611539438308

From Halozyme Therapeutics stock forecast 2025, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2025 is $40.8342112793204

From Halozyme Therapeutics stock forecast 2026, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2026 is $41.8015857846114

From Halozyme Therapeutics stock forecast 2030, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2030 is $38.7672159641793

From Halozyme Therapeutics stock forecast 2031, Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to AI Pickup, the Halozyme Therapeutics stock price forecast for Apr. 2031 is $35.080255920107

Is Halozyme Therapeutics stock overvalued?

Halozyme Therapeutics (HALO) stock is expected to go DOWN . Therefore, AI Pickup would say that Halozyme Therapeutics (HALO) stock is overvalued.

Will Halozyme Therapeutics stock price go up?

No. The Halozyme Therapeutics stock price forecast for Apr. 2022 is $35.8611539438308

Is Halozyme Therapeutics stock a good buy now?

Since closing price on 2021-04-09 is $42.77 and forecast for Apr. 2022 is $35.86, Halozyme Therapeutics stock is not a good 1 year investment.

14 Days Historical Data for Halozyme Therapeutics stock price

Date
Close
Open
Low
High
HALO stock price for 2021-03-22
$44.15
$43.33
$43.18
$44.9
HALO stock price for 2021-03-23
$43.09
$44.02
$42.55
$44.04
HALO stock price for 2021-03-24
$41.51
$43.28
$41.51
$43.51
HALO stock price for 2021-03-25
$41.3
$41.1
$40.32
$42.0
HALO stock price for 2021-03-26
$41.41
$41.52
$40.44
$42.27
HALO stock price for 2021-03-29
$40.45
$41.0
$40.29
$41.64
HALO stock price for 2021-03-30
$41.09
$40.33
$40.26
$41.65
HALO stock price for 2021-03-31
$41.69
$41.44
$41.06
$42.4
HALO stock price for 2021-04-01
$42.43
$42.27
$41.39
$43.26
HALO stock price for 2021-04-05
$42.93
$42.61
$42.1
$43.04
HALO stock price for 2021-04-06
$42.56
$42.91
$42.35
$43.56
HALO stock price for 2021-04-07
$42.35
$42.45
$42.2
$42.96
HALO stock price for 2021-04-08
$42.2
$42.69
$42.01
$43.09
HALO stock price for 2021-04-09
$42.77
$42.24
$41.69
$42.98
    • About
    • Company
    • Contact
    • Terms of Use
    • Privacy Policy
    • Risk Warning
    • COPYRIGHT © 2020 - 2021 by AI Pickup. All rights reserved.
    Risk Disclosure: Trading in any financial instruments including but not limited to stocks, ETF, bond, and forex and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount. Past results/performance of AI Pickup should not be any indication of any future results. You should make any investment after consulting your financial advisor and conducting your own research and due diligence. We exclude any and all liability for Our Content. Our Content shall not qualify as investment advice, counseling or any other information serving as a basis of investment (selling, purchasing, etc.) decisions.